- Home
- NVCR vs GENI Comparison
NVCR vs GENI Comparison
Compare NVCR & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCR | GENI |
|---|---|---|
| Founded | 2000 | 2016 |
| Country | Switzerland | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NVCR | GENI |
|---|---|---|
| Price | $14.70 | $6.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 21 |
| Target Price | ★ $26.86 | $10.83 |
| AVG Volume (30 Days) | 1.2M | ★ 7.9M |
| Earning Date | 10-29-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $655,353,000.00 | N/A |
| Revenue This Year | $10.80 | $51.71 |
| Revenue Next Year | $10.83 | $28.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.28 | N/A |
| 52 Week Low | $9.82 | $3.83 |
| 52 Week High | $21.45 | $12.39 |
Technical Indicators
Market Signals| Indicator | NVCR | GENI |
|---|---|---|
| Relative Strength Index (RSI) | 37.07 | 51.47 |
| Support Level | $13.12 | $5.50 |
| Resistance Level | $15.19 | $6.74 |
| Average True Range (ATR) | 0.62 | 0.36 |
| MACD | -0.12 | 0.11 |
| Stochastic Oscillator | 29.51 | 81.14 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas: Sports Technology and Services; Betting Technology, Content, and Services; and Media Technology, Content, and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content, and Services division. Geographically, the company derives a majority of its revenue from America.